Authors:
Saedi, MS
Zhu, Z
Marker, K
Liu, RS
Carpenter, PM
Rittenhouse, H
Mikolajczyk, SD
Citation: Ms. Saedi et al., Human kallikrein 2 (hK2), but not prostate-specific antigen (PSA), rapidlycomplexes with protease inhibitor 6 (PI-6) released from prostate carcinoma cells, INT J CANC, 94(4), 2001, pp. 558-563
Authors:
Mikolajczyk, SD
Marker, KM
Millar, LS
Kumar, A
Saedi, MS
Payne, JK
Evans, CL
Gasior, CL
Linton, HJ
Carpenter, P
Rittenhouse, HG
Citation: Sd. Mikolajczyk et al., A truncated precursor form of prostate-specific antigen is a more specificserum marker of prostate cancer, CANCER RES, 61(18), 2001, pp. 6958-6963
Authors:
Mikolajczyk, SD
Millar, LS
Marker, KM
Wang, TJ
Rittenhouse, HG
Marks, LS
Slawin, KM
Citation: Sd. Mikolajczyk et al., Seminal plasma contains "BPSA," a molecular form of prostate-specific antigen that is associated with benign prostatic hyperplasia, PROSTATE, 45(3), 2000, pp. 271-276
Authors:
Kumar, A
Mikolajczyk, SD
Hill, TM
Millar, LS
Saedi, MS
Citation: A. Kumar et al., Different proportions of various prostate-specific antigen (PSA) and humankallikrein 2 (hK2) forms are present in noninduced and androgen-induced LNCaP cells, PROSTATE, 44(3), 2000, pp. 248-254
Authors:
Mikolajczyk, SD
Millar, LS
Wang, TJ
Rittenhouse, HG
Wolfert, RL
Marks, LS
Song, WT
Wheeler, TM
Slawin, KM
Citation: Sd. Mikolajczyk et al., "BPSA," a specific molecular form of free prostate-specific antigen, is found predominantly in the transition zone of patients with nodular benign prostatic hyperplasia, UROLOGY, 55(1), 2000, pp. 41-45
Authors:
Wang, TJ
Slawin, KM
Rittenhouse, HG
Millar, LS
Mikolajczyk, SD
Citation: Tj. Wang et al., Benign prostatic hyperplasia-associated prostate-specific antigen (BPSA) shows unique immunoreactivity with anti-PSA monoclonal antibodies, EUR J BIOCH, 267(13), 2000, pp. 4040-4045
Authors:
Mikolajczyk, SD
Millar, LS
Wang, TJ
Rittenhouse, HG
Marks, LS
Song, WT
Wheeler, TM
Slawin, KM
Citation: Sd. Mikolajczyk et al., A precursor form of prostate-specific antigen is more highly elevated in prostate cancer compared with benign transition zone prostate tissue, CANCER RES, 60(3), 2000, pp. 756-759
Authors:
Kumar, A
Goel, AS
Payne, JK
Evans, C
Mikolajczyk, SD
Kuus-Reichel, K
Saedi, MS
Citation: A. Kumar et al., Large-scale propagation of recombinant adherent cells that secrete a stable form of human glandular kallikrein, hK2, PROT EX PUR, 15(1), 1999, pp. 62-68
Authors:
Mikolajczyk, SD
Millar, LS
Kumar, A
Saedi, MS
Citation: Sd. Mikolajczyk et al., Prostatic human kallikrein 2 inactivates and complexes with plasminogen activator inhibitor-1, INT J CANC, 81(3), 1999, pp. 438-442
Authors:
Mikolajczyk, SD
Millar, LS
Marker, KM
Rittenhouse, HG
Wolfert, RL
Marks, LS
Charlesworth, MC
Tindall, DJ
Citation: Sd. Mikolajczyk et al., Identification of a novel complex between human kallikrein 2 and protease inhibitor-6 in prostate cancer tissue, CANCER RES, 59(16), 1999, pp. 3927-3930